CBD Global Sciences EV / EBITDA
Mi az CBD Global Sciences EV / EBITDA?
A EV / EBITDA az CBD Global Sciences Inc. - N/A
Mi a EV / EBITDA meghatározása?
Az EV / EBITDA a vállalati érték a kamat, az adózás, az értékcsökkenés és az amortizáció előtti eredményekkel elosztva. Ez azt jelenti, hogy mennyire drága egy állomány, és gyakrabban érvényesül a vállalatok közötti összehasonlításnál, mint az ár / nyereség arány. Megméri az árat (vállalati érték formájában), amelyet a befektető fizet a vállalat pénzforgalmának javára (EBITDA formájában).
Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.
EV / EBITDA a Health Care szektor a OTC-on cégekben a CBD Global Sciences -hoz képest
Mit csinál CBD Global Sciences?
CBD Global Sciences Inc. engages in cannabidiol (CBD) farming, processing, and product manufacturing business. It offers provides biomass, CBD oil, and CBD oil products under the Aethics, CannaOil, and Strasburg Pharms brand names. The company was incorporated in 2018 and is headquartered in Lakewood, Colorado.
ev / ebitda -hoz hasonló cégek CBD Global Sciences
- Atomo Diagnostics nak EV / EBITDA N/A van
- LXRandCo nak EV / EBITDA N/A van
- Exro Technologies Inc nak EV / EBITDA N/A van
- Pacific Imperial Mines nak EV / EBITDA N/A van
- Kalina Power nak EV / EBITDA N/A van
- TransAtlantic Petroleum Ltd nak EV / EBITDA N/A van
- CBD Global Sciences nak EV / EBITDA N/A van
- Paradigm Biopharmaceuticals nak EV / EBITDA N/A van
- Guided Therapeutics nak EV / EBITDA N/A van
- KRM22 Plc nak EV / EBITDA N/A van
- CMC Metals nak EV / EBITDA N/A van
- Lamaska Capital nak EV / EBITDA N/A van
- Riverside Resources nak EV / EBITDA N/A van